Skip to main content

Validating Type 1 and Type 2 Diabetes Mellitus in the Mini-Sentinel Distributed Database using the Surveillance PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) DataLink

Basic Details
Date Posted
Status
Complete
Health Outcome(s)
diabetes
type 1 diabetes mellitus
type 2 diabetes mellitus
Description

The purpose of this project was to conduct a validation study for Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM) in the Mini-Sentinel Distributed Database (MSDD) using the SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) DataLink data from five Mini-Sentinel Data Partner sites that are also SUPREME-DM sites to examine the following two aims.

  • Aim 1: Demonstrate the feasibility of linking the MSDD and the SUPREME-DM DataLink.
  • Aim 2: Determine the sensitivity and positive predictive value (PPV) of the diagnosis codes and medication claims for patients with T1DM, T2DM, and any DM (e.g., inclusive of T1DM, T1DM, and DM of uncertain types) present in the MSDD, compared to the DataLink as the gold standard.
Deliverable(s) (1)
Validating Type 1 and Type 2 Diabetes Mellitus in the Mini-Sentinel Distributed Database Using the SUPREME-DM
Information
Data Source(s)
Mini-Sentinel Distributed Database (MSDD)
Workgroup Leader(s)

Marsha A. Raebel, PharmD; Kaiser Permanente Colorado, Institute for Health Research, Denver, CO

Azadeh Shoaibi, PhD, MHS, MS; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 

Workgroup Member(s)

Carlos Bell, MPH; Aaron Niman; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 

Nikki Carroll, MS; Glenn Goodrich, MS; Andrea R. Paolino, MA; John F. Steiner, MD, MPH; Kaiser Permanente Colorado, Institute for Health Research, Denver, CO

Terese A. DeFor; Jody Jackson; Pam Pawloski, PharmD; HealthPartners Institute for Education and Research, Minneapolis, MN

William Troy Donahoo; Colorado Permanente Medical Group Denver, CO

Sandra Feibelmann, MPH; Candace Fuller, PhD; Jennifer Popovic, DVM, MA; Ryan M. Saliga; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Monica Fujii, MPH; Katherine M. Newton, PhD; Roy Pardee, JD, MS; Group Health Research Institute, Seattle, WA

Jack Hamilton; Julie Schmittdiel, PhD; Deanne Wiley; Kaiser Permanente Northern California, Division of Research, Oakland, CA

Gregory A Nichols, PhD; Amanda Petrik, MS; Daniel S. Sapp; Xiuhai Yang, MS; Kaiser Permanente Northwest, Center for Health Research, Portland, OR

Emily B. Schroeder, MD, PhD; Kaiser Permanente Colorado, Institute for Health Research and Colorado Permanente Medical Group, Denver, CO